These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 20837798

  • 1. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
    Genead MA, Fishman GA.
    Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S, Fishman GA, Fiscella RG, Adelman AE.
    Retina; 1997 Sep; 17(3):222-31. PubMed ID: 9196934
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA, Fishman GA, Walia S.
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [Abstract] [Full Text] [Related]

  • 5. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
    Ikeda Y, Hisatomi T, Yoshida N, Notomi S, Murakami Y, Enaida H, Ishibashi T.
    Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Giuffre G.
    Am J Ophthalmol; 2006 Oct; 142(4):707; author reply 707-8. PubMed ID: 17011883
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
    Thobani A, Fishman GA.
    Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. DEXAMETHASONE IMPLANT VERSUS TOPICAL CARBONIC ANHYDRASE INHIBITORS IN PATIENTS WITH BILATERAL RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA: A Prospective, Paired-Eye Pilot Study.
    Colombo L, Montesano G, Di Domenico A, Colizzi B, Rissotto R, Maltese P, Bertelli M, Autelitano A, Rossetti L.
    Retina; 2024 May 01; 44(5):852-860. PubMed ID: 38166238
    [Abstract] [Full Text] [Related]

  • 15. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
    Bušić M, Bjeloš M, Bosnar D, Ramić S, Bušić I.
    Doc Ophthalmol; 2016 Feb 01; 132(1):67-73. PubMed ID: 26803827
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.
    Genead MA, McAnany JJ, Fishman GA.
    Retina; 2012 Apr 01; 32(4):826-33. PubMed ID: 21886018
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.